Keynote 937

Trial description
Adjuvant Therapy with Pembrolizumab Versus Placebo in Participants with Hepatocellular Carcinoma and Complete Radiological Response after Surgical Resection or Local Ablation
Contact name
Dr Bristi Basu
Trial start date
Friday, August 2, 2019
Trial end date
Wednesday, June 30, 2021
Trial tumour type
Liver & Bile Duct
Show on Radiotherapy
No